Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines

BACKGROUND AND PURPOSE: Oxaliplatin is the first platinum-based compound effective in the treatment of colorectal cancer. Oxaliplatin combined with cetuximab for metastatic colorectal cancer is under evaluation. The preliminary results seem controversial, particularly for the use of cetuximab in K-R...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Dahan, Laetitia, Sadok, Amine, Formento, Jean-Louis, Seitz, Jean François, Kovacic, Hervé
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Ltd 2009
Ämnen:
Research Papers
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2757701/
https://ncbi.nlm.nih.gov/pubmed/19732064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1476-5381.2009.00341.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk